{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:58:23Z","timestamp":1781881103383,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92374101"],"award-info":[{"award-number":["92374101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242160"],"award-info":[{"award-number":["7242160"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7254438"],"award-info":[{"award-number":["7254438"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015083","name":"Peking University People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RDEB2024\\u201304"],"award-info":[{"award-number":["RDEB2024\\u201304"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119101","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:22:40Z","timestamp":1770981760000},"page":"119101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identifying novel biomarkers for systemic lupus erythematosus associated with macrophage activation syndrome"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-7086","authenticated-orcid":false,"given":"Yuanyuan","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renge","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119101_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic Lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119101_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic Lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev. Pathol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119101_bib3","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Shakoory","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2026.119101_bib4","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/1756-185X.13955","article-title":"Clinical analysis of macrophage activation syndrome in adult rheumatic disease: a multicenter retrospective study","volume":"23","author":"Ke","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2026.119101_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s10067-022-06055-9","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients","volume":"41","author":"Wafa","year":"2022","journal-title":"Clin. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2026.119101_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119101_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2016.09.016","article-title":"Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers","volume":"16","author":"Ruscitti","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2026.119101_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat. Rev. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2026.119101_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","article-title":"Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases","volume":"46","author":"Batu","year":"2017","journal-title":"Scand. J. Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2026.119101_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.39329","article-title":"Editorial: 21st Century Storm Chasers: Defining Macrophage Activation Syndrome","volume":"68","author":"Scott","year":"2016","journal-title":"Arthritis Rheuma"},{"issue":"10","key":"10.1016\/j.biopha.2026.119101_bib11","first-page":"1934","article-title":"The systemic lupus activity measure-revised, the mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus[J]","volume":"31","author":"Am\u00e9rica","year":"2004","journal-title":"J. Rheuma"},{"issue":"9","key":"10.1016\/j.biopha.2026.119101_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119101_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.biopha.2026.119101_bib14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2026.119101_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.biopha.2026.119101_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"26","key":"10.1016\/j.biopha.2026.119101_bib17","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1182\/blood-2009-01-199588","article-title":"KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells","volume":"113","author":"Henson","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2026.119101_bib18","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.4049\/jimmunol.174.10.6088","article-title":"Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57","volume":"174","author":"Ibegbu","year":"2005","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.biopha.2026.119101_bib19","doi-asserted-by":"crossref","first-page":"12112","DOI":"10.1128\/JVI.79.18.12112-12116.2005","article-title":"Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T Cells during persistent antigen stimulation","volume":"79","author":"Thimme","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119101_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.20051986","article-title":"Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity","volume":"203","author":"Ito","year":"2006","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.biopha.2026.119101_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/gene.2009.38","article-title":"Identification of new SLE-associated genes with a two-step Bayesian study design","volume":"10","author":"Armstrong","year":"2009","journal-title":"Genes Immun."},{"issue":"4","key":"10.1016\/j.biopha.2026.119101_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/09612033231160979","article-title":"KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro","volume":"32","author":"Novelli","year":"2023","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.biopha.2026.119101_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5114\/reum.2021.110318","article-title":"Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus","volume":"59","author":"Kalim","year":"2021","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.biopha.2026.119101_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/IR:30:1:029","article-title":"The role of CD94\/NKG2 in innate and adaptive immunity","volume":"30","author":"Gunturi","year":"2004","journal-title":"Immunol. Res"},{"issue":"11","key":"10.1016\/j.biopha.2026.119101_bib25","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.4049\/jimmunol.157.11.4741","article-title":"Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits","volume":"157","author":"Lazetic","year":"1996","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119101_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s002510050420","article-title":"The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex","volume":"48","author":"Glienke","year":"1998","journal-title":"Immunogenetics"},{"issue":"6","key":"10.1016\/j.biopha.2026.119101_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10067-014-2547-9","article-title":"Meta-analysis of gene expression profiles to predict response to biologic agents in rheumatoid arthritis","volume":"33","author":"Lee","year":"2014","journal-title":"Clin. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2026.119101_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.biopha.2026.119101_bib29","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4161\/auto.7.12.18027","article-title":"Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction","volume":"7","author":"Alers","year":"2011","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.biopha.2026.119101_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/annrheumdis-2018-213181","article-title":"REDD1\/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)","volume":"78","author":"Frangou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2026.119101_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/eji.201847679","article-title":"Autophagy and immunological aberrations in systemic lupus erythematosus","volume":"49","author":"Qi","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"10126","key":"10.1016\/j.biopha.2026.119101_bib32","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:42:01Z","timestamp":1781880121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"alternative-id":["S0753332226001332"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119101","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying novel biomarkers for systemic lupus erythematosus associated with macrophage activation syndrome","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119101"}}